Jihane Tannous
Overview
Explore the profile of Jihane Tannous including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell
. 2022 Sep;
40(9):999-1009.e6.
PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
2.
Sol N, In t Veld S, Vancura A, Tjerkstra M, Leurs C, Rustenburg F, et al.
Cell Rep Med
. 2020 Oct;
1(7):100101.
PMID: 33103128
Tumor-educated platelets (TEPs) are potential biomarkers for cancer diagnostics. We employ TEP-derived RNA panels, determined by . We assessed specificity by comparing the spliced RNA profile of TEPs from glioblastoma...
3.
Castellanos-Rizaldos E, Grimm D, Tadigotla V, Hurley J, Healy J, Neal P, et al.
Clin Cancer Res
. 2018 Mar;
24(12):2944-2950.
PMID: 29535126
About 60% of non-small cell lung cancer (NSCLC) patients develop resistance to targeted epidermal growth factor receptor (EGFR) inhibitor therapy through the T790M mutation. Patients with this mutation respond well...
4.
Best M, Sol N, In t Veld S, Vancura A, Muller M, Niemeijer A, et al.
Cancer Cell
. 2017 Aug;
32(2):238-252.e9.
PMID: 28810146
Blood-based liquid biopsies, including tumor-educated blood platelets (TEPs), have emerged as promising biomarker sources for non-invasive detection of cancer. Here we demonstrate that particle-swarm optimization (PSO)-enhanced algorithms enable efficient selection...
5.
Nilsson R, Karachaliou N, Berenguer J, Gimenez-Capitan A, Schellen P, Teixido C, et al.
Oncotarget
. 2015 Nov;
7(1):1066-75.
PMID: 26544515
Purpose: Non-small-cell lung cancers harboring EML4-ALK rearrangements are sensitive to crizotinib. However, despite initial response, most patients will eventually relapse, and monitoring EML4-ALK rearrangements over the course of treatment may...
6.
Best M, Sol N, Kooi I, Tannous J, Westerman B, Rustenburg F, et al.
Cancer Cell
. 2015 Nov;
28(5):666-676.
PMID: 26525104
Tumor-educated blood platelets (TEPs) are implicated as central players in the systemic and local responses to tumor growth, thereby altering their RNA profile. We determined the diagnostic potential of TEPs...